Subscribe To Our Newsletter
Subscribe To Our Newsletter
If you purchased Tru Niagen capsules believing the product was clinically proven to provide cellular repair and anti-aging benefits, you don’t stand alone. This class action lawsuit seeks to represent a nationwide class of consumers, as well as a specific subclass of California residents, who bought the supplement for personal use.
A new class action lawsuit alleges that ChromaDex, Inc. (now known as Niagen Bioscience, Inc.) falsely advertises its popular dietary supplement, Tru Niagen. The lawsuit claims the company lacks sound scientific evidence to support its claims that the supplement is clinically proven to provide substantial cell-repairing health benefits. Everyday consumers are purchasing the product based on misleading cellular health promises, according to the complaint filed in California federal court.
The core of the class action lawsuit focuses on how the manufacturer markets Tru Niagen to the public. Advertisements for the supplement frequently claim that it is clinically proven to boost Nicotinamide Adenine Dinucleotide (NAD+), a vital coenzyme found in every cell of the human body that naturally declines as people age. According to marketing materials, elevating these levels directly translates to increased cellular energy, defense, and repair.
However, the plaintiff argues that the company’s heavy reliance on the phrase “clinically proven” misleads everyday people. The lawsuit contends that while certain studies might show a temporary increase in blood biomarkers, there is a severe lack of definitive human clinical data proving that oral capsules translate into tangible, systemic anti-aging health benefits or long-term cell maintenance. Plaintiffs allege that the company uses clinical terminology to create a false sense of scientific certainty, inducing consumers to pay a premium price for unverified wellness outcomes.
Intracellular NAD+ depletion is widely understood to contribute to age-related changes in physical vitality, which has turned cellular health into a multi-billion-dollar industry. Tru Niagen contains nicotinamide riboside (NR), an ingredient marketed as the gold-standard precursor designed to efficiently enter human cells and stimulate NAD+ production.
Because consumers are increasingly highly motivated to invest in their long-term health, the promise of a scientific shortcut to cellular repair is highly lucrative. The lawsuit notes that everyday people routinely spend significant money on the supplement under the impression that its specific health results—such as improved cognitive function, cardiovascular health, and muscle recovery—are firmly established by medical science. The legal complaint challenges this premise, stating that the company has overstepped the boundaries of honest marketing by presenting structural theories as hard, clinically verified facts.
Dietary supplements in the United States are governed under a unique regulatory framework. While prescription drugs must undergo rigorous clinical trials to prove both safety and efficacy before they hit the market, dietary supplements do not face the same pre-market approval process by the Food and Drug Administration (FDA). Instead, supplement manufacturers are legally responsible for ensuring that their advertising claims are truthful and backed by competent, reliable scientific evidence.
When a company advertises a product as “clinically proven” to achieve a health outcome without sufficient data to back it up, it may violate state consumer protection laws. This lawsuit explicitly invokes California’s Unfair Competition Law, False Advertising Law, and the Consumer Legal Remedies Act. These statutes are designed to protect you from deceptive business practices, ensuring that corporations cannot exploit gaps in federal oversight to sell products under false pretenses.
If you purchased Tru Niagen capsules believing the product was clinically proven to provide cellular repair and anti-aging benefits, you don’t stand alone. This class action lawsuit seeks to represent a nationwide class of consumers, as well as a specific subclass of California residents, who bought the supplement for personal use.
You may be eligible to participate or eventually collect compensation if you purchased Tru Niagen within the applicable statute of limitations period. Class action lawsuits of this nature typically seek to recover out-of-pocket losses for consumers, arguing that buyers would not have purchased the supplement—or would have paid significantly less for it—had they known the clinical claims were allegedly unproven. At this stage, no settlement money is available, and a final filing deadline for claims has not yet been established.
New cases and investigations, settlement deadlines, and news straight to your inbox.
